Medical Care
Global Vaccines & Vaccination Market Research Report 2025
- Sep 06, 25
- ID: 492882
- Pages: 87
- Figures: 88
- Views: 11
This report aims to provide a comprehensive presentation of the global market for Vaccines & Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccines & Vaccination.
The Vaccines & Vaccination market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines & Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines & Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Segment by Type
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Segment by Application
Baby Vaccine
Adult Special Vaccine
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccines & Vaccination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Vaccines & Vaccination market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Vaccines & Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vaccines & Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
AstraZeneca
Bavarian Nordic
Novartis
Bharat Biotech
Bio-Med
CSL
Emergent BioSolutions
GSK
Johnson & Johnson
Pfizer
Merck
Sanofi
Segment by Type
Subunit vaccines
Live attenuated vaccines
Conjugate vaccines
Inactivated vaccines
Recombinant vector vaccines
Toxoid vaccines
Synthetic vaccines
Dendritic cell vaccines
Segment by Application
Baby Vaccine
Adult Special Vaccine
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccines & Vaccination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccines & Vaccination Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Subunit vaccines
1.2.3 Live attenuated vaccines
1.2.4 Conjugate vaccines
1.2.5 Inactivated vaccines
1.2.6 Recombinant vector vaccines
1.2.7 Toxoid vaccines
1.2.8 Synthetic vaccines
1.2.9 Dendritic cell vaccines
1.3 Market by Application
1.3.1 Global Vaccines & Vaccination Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Baby Vaccine
1.3.3 Adult Special Vaccine
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccines & Vaccination Market Perspective (2020-2031)
2.2 Global Vaccines & Vaccination Growth Trends by Region
2.2.1 Global Vaccines & Vaccination Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vaccines & Vaccination Historic Market Size by Region (2020-2025)
2.2.3 Vaccines & Vaccination Forecasted Market Size by Region (2026-2031)
2.3 Vaccines & Vaccination Market Dynamics
2.3.1 Vaccines & Vaccination Industry Trends
2.3.2 Vaccines & Vaccination Market Drivers
2.3.3 Vaccines & Vaccination Market Challenges
2.3.4 Vaccines & Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccines & Vaccination Players by Revenue
3.1.1 Global Top Vaccines & Vaccination Players by Revenue (2020-2025)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Players (2020-2025)
3.2 Global Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vaccines & Vaccination Revenue
3.4 Global Vaccines & Vaccination Market Concentration Ratio
3.4.1 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccines & Vaccination Revenue in 2024
3.5 Global Key Players of Vaccines & Vaccination Head office and Area Served
3.6 Global Key Players of Vaccines & Vaccination, Product and Application
3.7 Global Key Players of Vaccines & Vaccination, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccines & Vaccination Breakdown Data by Type
4.1 Global Vaccines & Vaccination Historic Market Size by Type (2020-2025)
4.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2026-2031)
5 Vaccines & Vaccination Breakdown Data by Application
5.1 Global Vaccines & Vaccination Historic Market Size by Application (2020-2025)
5.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vaccines & Vaccination Market Size (2020-2031)
6.2 North America Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vaccines & Vaccination Market Size by Country (2020-2025)
6.4 North America Vaccines & Vaccination Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccines & Vaccination Market Size (2020-2031)
7.2 Europe Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vaccines & Vaccination Market Size by Country (2020-2025)
7.4 Europe Vaccines & Vaccination Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccines & Vaccination Market Size (2020-2031)
8.2 Asia-Pacific Vaccines & Vaccination Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vaccines & Vaccination Market Size by Region (2020-2025)
8.4 Asia-Pacific Vaccines & Vaccination Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccines & Vaccination Market Size (2020-2031)
9.2 Latin America Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vaccines & Vaccination Market Size by Country (2020-2025)
9.4 Latin America Vaccines & Vaccination Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccines & Vaccination Market Size (2020-2031)
10.2 Middle East & Africa Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vaccines & Vaccination Market Size by Country (2020-2025)
10.4 Middle East & Africa Vaccines & Vaccination Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccines & Vaccination Introduction
11.1.4 Abbott Revenue in Vaccines & Vaccination Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccines & Vaccination Introduction
11.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 Bavarian Nordic
11.3.1 Bavarian Nordic Company Details
11.3.2 Bavarian Nordic Business Overview
11.3.3 Bavarian Nordic Vaccines & Vaccination Introduction
11.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2020-2025)
11.3.5 Bavarian Nordic Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Vaccines & Vaccination Introduction
11.4.4 Novartis Revenue in Vaccines & Vaccination Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Bharat Biotech
11.5.1 Bharat Biotech Company Details
11.5.2 Bharat Biotech Business Overview
11.5.3 Bharat Biotech Vaccines & Vaccination Introduction
11.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2020-2025)
11.5.5 Bharat Biotech Recent Development
11.6 Bio-Med
11.6.1 Bio-Med Company Details
11.6.2 Bio-Med Business Overview
11.6.3 Bio-Med Vaccines & Vaccination Introduction
11.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2020-2025)
11.6.5 Bio-Med Recent Development
11.7 CSL
11.7.1 CSL Company Details
11.7.2 CSL Business Overview
11.7.3 CSL Vaccines & Vaccination Introduction
11.7.4 CSL Revenue in Vaccines & Vaccination Business (2020-2025)
11.7.5 CSL Recent Development
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Company Details
11.8.2 Emergent BioSolutions Business Overview
11.8.3 Emergent BioSolutions Vaccines & Vaccination Introduction
11.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2020-2025)
11.8.5 Emergent BioSolutions Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Vaccines & Vaccination Introduction
11.9.4 GSK Revenue in Vaccines & Vaccination Business (2020-2025)
11.9.5 GSK Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Vaccines & Vaccination Introduction
11.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2020-2025)
11.10.5 Johnson & Johnson Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Vaccines & Vaccination Introduction
11.11.4 Pfizer Revenue in Vaccines & Vaccination Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Vaccines & Vaccination Introduction
11.12.4 Merck Revenue in Vaccines & Vaccination Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Vaccines & Vaccination Introduction
11.13.4 Sanofi Revenue in Vaccines & Vaccination Business (2020-2025)
11.13.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccines & Vaccination Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Subunit vaccines
1.2.3 Live attenuated vaccines
1.2.4 Conjugate vaccines
1.2.5 Inactivated vaccines
1.2.6 Recombinant vector vaccines
1.2.7 Toxoid vaccines
1.2.8 Synthetic vaccines
1.2.9 Dendritic cell vaccines
1.3 Market by Application
1.3.1 Global Vaccines & Vaccination Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Baby Vaccine
1.3.3 Adult Special Vaccine
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Vaccines & Vaccination Market Perspective (2020-2031)
2.2 Global Vaccines & Vaccination Growth Trends by Region
2.2.1 Global Vaccines & Vaccination Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Vaccines & Vaccination Historic Market Size by Region (2020-2025)
2.2.3 Vaccines & Vaccination Forecasted Market Size by Region (2026-2031)
2.3 Vaccines & Vaccination Market Dynamics
2.3.1 Vaccines & Vaccination Industry Trends
2.3.2 Vaccines & Vaccination Market Drivers
2.3.3 Vaccines & Vaccination Market Challenges
2.3.4 Vaccines & Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccines & Vaccination Players by Revenue
3.1.1 Global Top Vaccines & Vaccination Players by Revenue (2020-2025)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Players (2020-2025)
3.2 Global Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Vaccines & Vaccination Revenue
3.4 Global Vaccines & Vaccination Market Concentration Ratio
3.4.1 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccines & Vaccination Revenue in 2024
3.5 Global Key Players of Vaccines & Vaccination Head office and Area Served
3.6 Global Key Players of Vaccines & Vaccination, Product and Application
3.7 Global Key Players of Vaccines & Vaccination, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccines & Vaccination Breakdown Data by Type
4.1 Global Vaccines & Vaccination Historic Market Size by Type (2020-2025)
4.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2026-2031)
5 Vaccines & Vaccination Breakdown Data by Application
5.1 Global Vaccines & Vaccination Historic Market Size by Application (2020-2025)
5.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Vaccines & Vaccination Market Size (2020-2031)
6.2 North America Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Vaccines & Vaccination Market Size by Country (2020-2025)
6.4 North America Vaccines & Vaccination Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Vaccines & Vaccination Market Size (2020-2031)
7.2 Europe Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Vaccines & Vaccination Market Size by Country (2020-2025)
7.4 Europe Vaccines & Vaccination Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Vaccines & Vaccination Market Size (2020-2031)
8.2 Asia-Pacific Vaccines & Vaccination Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Vaccines & Vaccination Market Size by Region (2020-2025)
8.4 Asia-Pacific Vaccines & Vaccination Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Vaccines & Vaccination Market Size (2020-2031)
9.2 Latin America Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Vaccines & Vaccination Market Size by Country (2020-2025)
9.4 Latin America Vaccines & Vaccination Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccines & Vaccination Market Size (2020-2031)
10.2 Middle East & Africa Vaccines & Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Vaccines & Vaccination Market Size by Country (2020-2025)
10.4 Middle East & Africa Vaccines & Vaccination Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccines & Vaccination Introduction
11.1.4 Abbott Revenue in Vaccines & Vaccination Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccines & Vaccination Introduction
11.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2020-2025)
11.2.5 AstraZeneca Recent Development
11.3 Bavarian Nordic
11.3.1 Bavarian Nordic Company Details
11.3.2 Bavarian Nordic Business Overview
11.3.3 Bavarian Nordic Vaccines & Vaccination Introduction
11.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2020-2025)
11.3.5 Bavarian Nordic Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Vaccines & Vaccination Introduction
11.4.4 Novartis Revenue in Vaccines & Vaccination Business (2020-2025)
11.4.5 Novartis Recent Development
11.5 Bharat Biotech
11.5.1 Bharat Biotech Company Details
11.5.2 Bharat Biotech Business Overview
11.5.3 Bharat Biotech Vaccines & Vaccination Introduction
11.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2020-2025)
11.5.5 Bharat Biotech Recent Development
11.6 Bio-Med
11.6.1 Bio-Med Company Details
11.6.2 Bio-Med Business Overview
11.6.3 Bio-Med Vaccines & Vaccination Introduction
11.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2020-2025)
11.6.5 Bio-Med Recent Development
11.7 CSL
11.7.1 CSL Company Details
11.7.2 CSL Business Overview
11.7.3 CSL Vaccines & Vaccination Introduction
11.7.4 CSL Revenue in Vaccines & Vaccination Business (2020-2025)
11.7.5 CSL Recent Development
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Company Details
11.8.2 Emergent BioSolutions Business Overview
11.8.3 Emergent BioSolutions Vaccines & Vaccination Introduction
11.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2020-2025)
11.8.5 Emergent BioSolutions Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Vaccines & Vaccination Introduction
11.9.4 GSK Revenue in Vaccines & Vaccination Business (2020-2025)
11.9.5 GSK Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Vaccines & Vaccination Introduction
11.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2020-2025)
11.10.5 Johnson & Johnson Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Vaccines & Vaccination Introduction
11.11.4 Pfizer Revenue in Vaccines & Vaccination Business (2020-2025)
11.11.5 Pfizer Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Vaccines & Vaccination Introduction
11.12.4 Merck Revenue in Vaccines & Vaccination Business (2020-2025)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Vaccines & Vaccination Introduction
11.13.4 Sanofi Revenue in Vaccines & Vaccination Business (2020-2025)
11.13.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Vaccines & Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Subunit vaccines
Table 3. Key Players of Live attenuated vaccines
Table 4. Key Players of Conjugate vaccines
Table 5. Key Players of Inactivated vaccines
Table 6. Key Players of Recombinant vector vaccines
Table 7. Key Players of Toxoid vaccines
Table 8. Key Players of Synthetic vaccines
Table 9. Global Vaccines & Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Vaccines & Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Vaccines & Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Vaccines & Vaccination Market Share by Region (2020-2025)
Table 13. Global Vaccines & Vaccination Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Vaccines & Vaccination Market Share by Region (2026-2031)
Table 15. Vaccines & Vaccination Market Trends
Table 16. Vaccines & Vaccination Market Drivers
Table 17. Vaccines & Vaccination Market Challenges
Table 18. Vaccines & Vaccination Market Restraints
Table 19. Global Vaccines & Vaccination Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Vaccines & Vaccination Market Share by Players (2020-2025)
Table 21. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2024)
Table 22. Ranking of Global Top Vaccines & Vaccination Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Vaccines & Vaccination Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Vaccines & Vaccination, Headquarters and Area Served
Table 25. Global Key Players of Vaccines & Vaccination, Product and Application
Table 26. Global Key Players of Vaccines & Vaccination, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Vaccines & Vaccination Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Vaccines & Vaccination Revenue Market Share by Type (2020-2025)
Table 30. Global Vaccines & Vaccination Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Vaccines & Vaccination Revenue Market Share by Type (2026-2031)
Table 32. Global Vaccines & Vaccination Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Vaccines & Vaccination Revenue Market Share by Application (2020-2025)
Table 34. Global Vaccines & Vaccination Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Vaccines & Vaccination Revenue Market Share by Application (2026-2031)
Table 36. North America Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Vaccines & Vaccination Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Vaccines & Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Vaccines & Vaccination Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Vaccines & Vaccination Product
Table 54. Abbott Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. AstraZeneca Company Details
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca Vaccines & Vaccination Product
Table 59. AstraZeneca Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Bavarian Nordic Company Details
Table 62. Bavarian Nordic Business Overview
Table 63. Bavarian Nordic Vaccines & Vaccination Product
Table 64. Bavarian Nordic Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 65. Bavarian Nordic Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Vaccines & Vaccination Product
Table 69. Novartis Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Bharat Biotech Company Details
Table 72. Bharat Biotech Business Overview
Table 73. Bharat Biotech Vaccines & Vaccination Product
Table 74. Bharat Biotech Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 75. Bharat Biotech Recent Development
Table 76. Bio-Med Company Details
Table 77. Bio-Med Business Overview
Table 78. Bio-Med Vaccines & Vaccination Product
Table 79. Bio-Med Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 80. Bio-Med Recent Development
Table 81. CSL Company Details
Table 82. CSL Business Overview
Table 83. CSL Vaccines & Vaccination Product
Table 84. CSL Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 85. CSL Recent Development
Table 86. Emergent BioSolutions Company Details
Table 87. Emergent BioSolutions Business Overview
Table 88. Emergent BioSolutions Vaccines & Vaccination Product
Table 89. Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 90. Emergent BioSolutions Recent Development
Table 91. GSK Company Details
Table 92. GSK Business Overview
Table 93. GSK Vaccines & Vaccination Product
Table 94. GSK Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 95. GSK Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Vaccines & Vaccination Product
Table 99. Johnson & Johnson Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 100. Johnson & Johnson Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Vaccines & Vaccination Product
Table 104. Pfizer Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Vaccines & Vaccination Product
Table 109. Merck Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi Vaccines & Vaccination Product
Table 114. Sanofi Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 115. Sanofi Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Vaccines & Vaccination Picture
Figure 2. Global Vaccines & Vaccination Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccines & Vaccination Market Share by Type: 2024 VS 2031
Figure 4. Subunit vaccines Features
Figure 5. Live attenuated vaccines Features
Figure 6. Conjugate vaccines Features
Figure 7. Inactivated vaccines Features
Figure 8. Recombinant vector vaccines Features
Figure 9. Toxoid vaccines Features
Figure 10. Synthetic vaccines Features
Figure 11. Dendritic cell vaccines Features
Figure 12. Global Vaccines & Vaccination Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Vaccines & Vaccination Market Share by Application: 2024 VS 2031
Figure 14. Baby Vaccine Case Studies
Figure 15. Adult Special Vaccine Case Studies
Figure 16. Other Case Studies
Figure 17. Vaccines & Vaccination Report Years Considered
Figure 18. Global Vaccines & Vaccination Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Vaccines & Vaccination Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Vaccines & Vaccination Market Share by Region: 2024 VS 2031
Figure 21. Global Vaccines & Vaccination Market Share by Players in 2024
Figure 22. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2024
Figure 24. North America Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 26. United States Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 30. Germany Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Vaccines & Vaccination Market Share by Region (2020-2031)
Figure 38. China Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 46. Mexico Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 50. Turkey Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Abbott Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 55. Bavarian Nordic Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 57. Bharat Biotech Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 58. Bio-Med Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 59. CSL Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 60. Emergent BioSolutions Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 61. GSK Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 62. Johnson & Johnson Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 63. Pfizer Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 64. Merck Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 65. Sanofi Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Table 1. Global Vaccines & Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Subunit vaccines
Table 3. Key Players of Live attenuated vaccines
Table 4. Key Players of Conjugate vaccines
Table 5. Key Players of Inactivated vaccines
Table 6. Key Players of Recombinant vector vaccines
Table 7. Key Players of Toxoid vaccines
Table 8. Key Players of Synthetic vaccines
Table 9. Global Vaccines & Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Vaccines & Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Vaccines & Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Vaccines & Vaccination Market Share by Region (2020-2025)
Table 13. Global Vaccines & Vaccination Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Vaccines & Vaccination Market Share by Region (2026-2031)
Table 15. Vaccines & Vaccination Market Trends
Table 16. Vaccines & Vaccination Market Drivers
Table 17. Vaccines & Vaccination Market Challenges
Table 18. Vaccines & Vaccination Market Restraints
Table 19. Global Vaccines & Vaccination Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Vaccines & Vaccination Market Share by Players (2020-2025)
Table 21. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2024)
Table 22. Ranking of Global Top Vaccines & Vaccination Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Vaccines & Vaccination Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Vaccines & Vaccination, Headquarters and Area Served
Table 25. Global Key Players of Vaccines & Vaccination, Product and Application
Table 26. Global Key Players of Vaccines & Vaccination, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Vaccines & Vaccination Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Vaccines & Vaccination Revenue Market Share by Type (2020-2025)
Table 30. Global Vaccines & Vaccination Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Vaccines & Vaccination Revenue Market Share by Type (2026-2031)
Table 32. Global Vaccines & Vaccination Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Vaccines & Vaccination Revenue Market Share by Application (2020-2025)
Table 34. Global Vaccines & Vaccination Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Vaccines & Vaccination Revenue Market Share by Application (2026-2031)
Table 36. North America Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Vaccines & Vaccination Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Vaccines & Vaccination Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Vaccines & Vaccination Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Vaccines & Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Vaccines & Vaccination Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Vaccines & Vaccination Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Vaccines & Vaccination Product
Table 54. Abbott Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. AstraZeneca Company Details
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca Vaccines & Vaccination Product
Table 59. AstraZeneca Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Bavarian Nordic Company Details
Table 62. Bavarian Nordic Business Overview
Table 63. Bavarian Nordic Vaccines & Vaccination Product
Table 64. Bavarian Nordic Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 65. Bavarian Nordic Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Vaccines & Vaccination Product
Table 69. Novartis Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Bharat Biotech Company Details
Table 72. Bharat Biotech Business Overview
Table 73. Bharat Biotech Vaccines & Vaccination Product
Table 74. Bharat Biotech Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 75. Bharat Biotech Recent Development
Table 76. Bio-Med Company Details
Table 77. Bio-Med Business Overview
Table 78. Bio-Med Vaccines & Vaccination Product
Table 79. Bio-Med Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 80. Bio-Med Recent Development
Table 81. CSL Company Details
Table 82. CSL Business Overview
Table 83. CSL Vaccines & Vaccination Product
Table 84. CSL Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 85. CSL Recent Development
Table 86. Emergent BioSolutions Company Details
Table 87. Emergent BioSolutions Business Overview
Table 88. Emergent BioSolutions Vaccines & Vaccination Product
Table 89. Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 90. Emergent BioSolutions Recent Development
Table 91. GSK Company Details
Table 92. GSK Business Overview
Table 93. GSK Vaccines & Vaccination Product
Table 94. GSK Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 95. GSK Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Vaccines & Vaccination Product
Table 99. Johnson & Johnson Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 100. Johnson & Johnson Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Vaccines & Vaccination Product
Table 104. Pfizer Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Vaccines & Vaccination Product
Table 109. Merck Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Sanofi Company Details
Table 112. Sanofi Business Overview
Table 113. Sanofi Vaccines & Vaccination Product
Table 114. Sanofi Revenue in Vaccines & Vaccination Business (2020-2025) & (US$ Million)
Table 115. Sanofi Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Vaccines & Vaccination Picture
Figure 2. Global Vaccines & Vaccination Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Vaccines & Vaccination Market Share by Type: 2024 VS 2031
Figure 4. Subunit vaccines Features
Figure 5. Live attenuated vaccines Features
Figure 6. Conjugate vaccines Features
Figure 7. Inactivated vaccines Features
Figure 8. Recombinant vector vaccines Features
Figure 9. Toxoid vaccines Features
Figure 10. Synthetic vaccines Features
Figure 11. Dendritic cell vaccines Features
Figure 12. Global Vaccines & Vaccination Market Size by Application (2020-2031) & (US$ Million)
Figure 13. Global Vaccines & Vaccination Market Share by Application: 2024 VS 2031
Figure 14. Baby Vaccine Case Studies
Figure 15. Adult Special Vaccine Case Studies
Figure 16. Other Case Studies
Figure 17. Vaccines & Vaccination Report Years Considered
Figure 18. Global Vaccines & Vaccination Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Vaccines & Vaccination Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Vaccines & Vaccination Market Share by Region: 2024 VS 2031
Figure 21. Global Vaccines & Vaccination Market Share by Players in 2024
Figure 22. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2024
Figure 24. North America Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 26. United States Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 30. Germany Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Vaccines & Vaccination Market Share by Region (2020-2031)
Figure 38. China Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 46. Mexico Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Vaccines & Vaccination Market Share by Country (2020-2031)
Figure 50. Turkey Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Vaccines & Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Abbott Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 55. Bavarian Nordic Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 57. Bharat Biotech Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 58. Bio-Med Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 59. CSL Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 60. Emergent BioSolutions Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 61. GSK Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 62. Johnson & Johnson Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 63. Pfizer Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 64. Merck Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 65. Sanofi Revenue Growth Rate in Vaccines & Vaccination Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232